TCS, Bharti Airtel see big value erosion this week
The benchmark Sensex dropped by 932.42 points or 1.11 per cent during the week, leading to heavy losses for several top companies.
TCS saw the biggest decline in valuation, losing Rs 56,279.35 crore and ending the week with a market cap of Rs 11.81 lakh crore.
The company's shares fell nearly 3.5 per cent on Friday after its June quarter results failed to meet investor expectations.
Bharti Airtel was the second-biggest loser, with its market valuation falling by Rs 54,483.62 crore to Rs 10.95 lakh crore.
Reliance Industries, Infosys, ICICI Bank, LIC, HDFC Bank and State Bank of India also ended the week with reduced valuations.
In total, eight of the top 10 most valued firms lost a combined Rs 2.07 lakh crore in market capitalisation.
On the brighter side, only two companies -- Hindustan Unilever Limited (HUL) and Bajaj Finance -- managed to end the week with gains.
HUL added Rs 42,363.13 crore to its value, driven by a nearly 5 per cent jump in share price on Friday after the company named Priya Nair as its first woman CEO and MD.
Bajaj Finance's valuation also rose by Rs 5,033.57 crore. Despite the losses, the most valued firms in India include HDFC Bank, TCS, Bharti Airtel, ICICI Bank, State Bank of India, Infosys, LIC, Bajaj Finance and Hindustan Unilever.
Meanwhile, the week was marked by volatility, with the Nifty slipping 311.15 points or 1.22 per cent to close at 25,149.85.
IT stocks led the decline, dragging the Nifty IT index down by 3.76 per cent. The Nifty Auto index fell 2.03 per cent, while Nifty Infra and Nifty Energy declined 1.88 per cent and 1.13 per cent, respectively.
However, FMCG stocks saw buying interest, with the Nifty FMCG index ending 2.15 per cent higher.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
21 minutes ago
- India.com
Good news for Pune! City to get 4 Vande Bharat trains connecting THESE places, Check fare, routes and other details here
वंदे भारत स्लीपर ट्रेन New Delhi: Good news for the people residing in Pune, the Indian Railways has announced the launch of four new Vande Bharat Express trains from Pune. According to the reports, the new trains will connect the city to Shegaon, Vadodara, Secunderabad, and Belagavi. These trains will cut travel time significantly and offer passengers enhanced comfort and convenience. It is important to note that currently, Pune city has two operational Vande Bharat Express trains running on the Pune-Kolhapur and Pune-Hubballi routes. With these four new services, the total number of Vande Bharat trains from Pune will rise to six. Here are some of the key details: Pune–Vadodara Vande Bharat: Possible halts at Lonavala, Panvel, Vapi, and Surat. Expected to reduce travel time from 9 hours to 6-7 hours. Pune–Shegaon Vande Bharat: Likely stops include Daund, Ahmednagar, Chhatrapati Sambhajinagar, and Jalna. Pune–Secunderabad Vande Bharat: The train will likely to stop at Daund, Solapur, and Gulbarga, saving 2-3 hours of travel time. Pune–Belagavi Vande Bharat: Likely halts at Satara, Sangli, and Miraj. Tickets are expected to cost between Rs 1,500 and Rs 2,000. In other news, the Indian Railways is also considering launching a Pune–Nagpur Vande Bharat Sleeper train, which will further boost connectivity. These new services aim to ease travel for passengers, promote tourism in connected regions, and give a fresh push to development around Pune.
India.com
21 minutes ago
- India.com
What is the rent of Mumbai showroom from which Elon Musk will sell Tesla cars in India? It is Rs...
Tesla has made its official entry into the Indian market with the launch of its first showroom in the country. Tesla's first Indian showroom, unveiled in Mumbai on Tuesday morning at the Maker Maxity Mall in the Bandra Kurla Complex (BKC), Mumbai. To engage with Indian buyers, the showroom also displays the Tesla name in Hindi. It was inaugurated by Maharashtra's Chief Minister Devendra Fadnavis. Tesla's car prices for the Indian market have already been disclosed, but do you know how much they are paying for their premium showroom that sells premium luxury cars? Tesla has launched its first showroom in India in the Bandra-Kurla Complex in Mumbai. The showroom, which is 4,000 square feet big, will not only provide an opportunity to buy a car, but it will also allow visitors to see Tesla's technology and features first-hand. For the time being, Tesla will sell the Model Y from this location. As per the media reports, Tesla has taken a 4,000 sq ft retail space on a 5-year lease, for mounting costs of monthly rent of around Rs 35 lakh and a total expenditure of more than Rs 25 crore. The electric Midsize SUV, the Tesla Model Y, is priced from nearly INR 60 lakhs. Currently, the Model Y will be the only model available in the country. It will be offered in two variants: Rear-Wheel Drive, priced at INR 60 lakhs, and Long Range Rear-Wheel Drive, priced at Rs 68 lakhs. Interior options include white and black themes, and the vehicle will feature a five-seat configuration. As of now, deliveries and registration are available only in Mumbai, Delhi, and Gurugram, as listed on Tesla's official portal. Pricing may vary depending on the state and applicable local taxes. Customers can also opt for Tesla's Full Self-Driving (FSD) package, which adds an additional cost of Rs 6 lakhs over the base prices. The Model Y will be available in six colour options, of which Stealth Grey is the only one offered at no additional charge. The other colours: Pearl White Multi-Coat, Diamond Black, Ultra Red, Quicksilver, and Glacier Blue, will come at an extra cost. Interior options include white and black themes, and the vehicle will feature a five-seat configuration.
Economic Times
21 minutes ago
- Economic Times
How should you position yourself in IT and pharma now? Neeraj Dewan answers
Neeraj Dewan, Market Expert suggests a cautious approach to IT stocks. The IT sector's result season is not promising. Investors should await clarity on earnings and US business trends. Holding TCS and Infosys might be wise. Pharma tariffs are creating confusion. Focus on individual pharma stocks. Investors should stay invested in their chosen stocks. Monitor tariff developments closely for potential impacts. ADVERTISEMENT After the TCS as well as HCL Technologies Q1 results, it seems like IT will need to be avoided this quarter too? Neeraj Dewan: Yes, definitely the beginning of the result season has not been good for IT. It was on expected lines because we are not expecting good results from IT this quarter and even the immediate outlook is not that clear. So, one should wait to get more clarity; one, what is going to happen on the earnings front and second, what clues we have from the US regarding business going ahead. So, one should really wait and see how it goes. As far as largecap IT is concerned, if TCS, Infosys consolidate in this region and stop correcting, maybe it is not a good idea to sell them at this point. One should hold on to them to get more clarity or start accumulating. A lot of things are happening in the pharma space. There is some stock specific action from Zydus Life, positive news flow coming in for Zydus as well as Biocon for their diabetes drug Kirsty. Other than that, there is some commentary coming in from Trump where he is saying that pharma tariffs could be announced by the end of this month. What is your take on the sector? How should investors position themselves in this sector? Neeraj Dewan: As far as the tariffs are concerned, there are two things. One, Trump has been speaking about pharma tariffs for quite some time. Off and on, he comes out with statements but the market has not reacted too much and stocks have been doing well. Second, there are these country specific deals. There is still no clarity if India will have a country-specific deal. If there will be separate tariffs for all industries, then what is the idea of having a country specific deal?There is a lot of confusion over tariffs as of now. So, I do not think stocks will react too much. For an investor, it would be best to just invest in the stocks we like and stay invested in them as far as pharma is concerned. Pharma has been a stock specific bet and one cannot really invest across because now the stocks are not that cheap. They are quite fairly valued. We will get pockets there. We will get stocks which are doing very well and stock specific moves will come. So, you should stay invested in the ones you are betting on and then see how it goes as far as the tariffs are concerned. Is there merit in looking at the two-wheeler space right now? Yesterday, the entire pack was fairly charged up. We have seen an early onset of monsoon as well. The distribution so far as well pretty much seems to be on course. Is that going to reflect in the two-wheeler numbers? Neeraj Dewan: Yes, I think so because bigger companies like Hero Motors and Bajaj Auto have come out with some statements. They are going to be aggressive and they are looking at growth going ahead. We have seen that if we have a good monsoon, there is definitely a pickup in demand in the two-wheeler space. Going ahead, since inflation is low, there is excess liquidity in the system, and we are having a good monsoon as well, it will all augur well for the sector. ADVERTISEMENT Hero Motor is trading at discount to its long-term averages. At this price, getting into Hero Motor should make sense for a long-term investor. Similarly, in Bajaj Auto, we are yet to see some improvement happening. Let us see the results for this quarter and then we will take a call on Bajaj Auto. Hero Motor definitely as they are quoting 20 times historical and Bajaj Auto is at close to 30 times historical; 12 months trailing are showing attractive valuations. One should consider them for long-term investing. In terms of the stock market, insurance has been a nonstarter barring a few odd moves here and there. How should insurance be looked at? It may be a structural story but the stocks have not performed at all. Neeraj Dewan: You are right, it is a structural story where five-six years back, everyone believed it would be a good value generator. But everyone got invested also. You see long-term portfolios, they are holding on to some good insurance stock. The funds have been holding on to them. But that follow-up big buying is not coming because there is no exceptional gain which comes specifically from life insurance companies. ADVERTISEMENT Life insurance companies have been a drag and going ahead, we are looking at 10-12% return. We can still get that kind of return in this sector. But general insurance is one where there is still good scope. There can be growth there and we have seen those companies doing better also. So, if I have to pick one of the two, I will pick general insurance. (You can now subscribe to our ETMarkets WhatsApp channel)
